World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism (Q33319816)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

Europe PubMed Central

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

0 references

0 references

biological psychiatry

1 reference

based on heuristic

inferred from title

Victor Hesselbrock

5

object named as

Victor Hesselbrock

0 references

Hans-Jürgen Möller

7

object named as

Hans-Jürgen Möller

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1

object named as

Michael Soyka

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Henry R. Kranzler

2

object named as

Henry R Kranzler

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Mats Berglund

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

David Gorelick

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Bankole A Johnson

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

WFSBP Task Force on Treatment Guidelines for Substance Use Disorders

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

6-23

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

The effects of alcohol and drug dependence on the course of depression

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Alcoholism treatment by disulfiram and community reinforcement therapy.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Efficacy of acamprosate in the treatment of alcohol-dependent outpatients

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: a formal multicentre doubl-blind comparison with placebo

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

The effectiveness of psychosocial treatment approaches for alcohol dependence--a review

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

The use of divalproex in alcohol relapse prevention: a pilot study

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Acamprosate blocks the increase in dopamine extracellular levels in nucleus accumbens evoked by chemical stimulation of the ventral hippocampus.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

A neurobiological basis for substance abuse comorbidity in schizophrenia

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Ethanol antagonizes kainate receptor-mediated inhibition of evoked GABA(A) inhibitory postsynaptic currents in the rat hippocampal CA1 region

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Association between GABRA1 and drinking behaviors in the collaborative study on the genetics of alcoholism sample

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Topiramate (Topamax) reduces conditioned abstinence behaviours and handling-induced convulsions (HIC) after chronic administration of alcohol in Swiss-Webster mice

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Disulfiram for the treatment of alcoholism. An evaluation in 128 men.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Effects of topiramate on ethanol and saccharin consumption and preferences in C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Pharmacological treatment of alcohol dependence: a review of the evidence

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Alcoholic hallucinosis: a psychiatric enigma--1. The development of an idea

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Alcoholic hallucinosis: a psychiatric enigma--2. Follow-up studies

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

The neurotoxicity induced by ethanol withdrawal in mature organotypic hippocampal slices might involve cross-talk between metabotropic glutamate type 5 receptors and N-methyl-D-aspartate receptors

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Alcoholism treatment and medical care costs from Project MATCH.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Neuropharmacological treatments for alcoholism: scientific basis and clinical findings

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Safety and efficacy of GABAergic medications for treating alcoholism

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Topiramate for treating alcohol dependence: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Spouse contracting to increase antabuse compliance in alcoholic veterans

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Effectiveness of naltrexone in a community treatment program

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Alcoholism: allostasis and beyond

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Effects of ondansetron in early- versus late-onset alcoholics: a prospective, open-label study

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Sertraline treatment of co-occurring alcohol dependence and major depression

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Randomized clinical trial of atenolol in patients with alcohol withdrawal.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Association between alcoholism and gamma-amino butyric acid alpha2 receptor subtype in a Russian population

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidity

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Chronic alcohol use and first symptomatic epileptic seizures

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Chlormethiazole: current status in the treatment of the acute ethanol withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Update on anticonvulsants for the treatment of alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Efficacy of buspirone in alcohol dependence: a review

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Management of alcohol withdrawal delirium. An evidence-based practice guideline

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Naltrexone for alcohol dependence: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Topiramate reduces ethanol consumption by C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Acamprosate and its efficacy in treating alcohol dependent adolescents

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Six-month outcomes for patients who switched to olanzapine treatment

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Experience of a "slip" among alcoholics treated with naltrexone or placebo

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Six-month follow-up of naltrexone and psychotherapy for alcohol dependence

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

A rational approach to the pharmacotherapy of alcohol dependence

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Double-blind clinical trial of sertraline treatment for alcohol dependence

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Currently active and remitted alcohol dependence in a nationwide adult general population--results from the Finnish Health 2000 study

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Paroxetine for social anxiety and alcohol use in dual-diagnosed patients

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Alcohol use disorders in EU countries and Norway: an overview of the epidemiology

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Comparison of induced and independent major depressive disorders in 2,945 alcoholics

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Candidate genes for alcohol dependence: animal studies

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Treatment of alcohol withdrawal: chlormethiazole vs. carbamazepine and the effect on memory performance--a pilot study

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Diazepam loading: simplified treatment of alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Clinical guidelines: developing guidelines

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Pharmacological treatment of substance-abusing schizophrenic patients

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

New pharmacological approaches for the treatment of alcoholism

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

A combination of carbamazepine/tiapride in outpatient alcohol detoxification. Results from an open clinical study

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Thalamic hypofunction in alcohol hallucinosis: FDG PET findings

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Efficacy and safety of outpatient alcohol detoxification with a combination of tiapride/carbamazepine: additional evidence

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

The dopamine hypothesis of reward: past and current status

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Clock reset for alcoholism

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

The prevalence and impact of alcohol problems in major depression: a systematic review

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Characteristics of men with alcoholic hallucinosis.

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Effect of naltrexone on alcohol "high" in alcoholics

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Pharmacotherapy of schizophrenia patients with comorbid substance abuse

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Project MATCH secondary a priori hypotheses

1 reference

https://api.crossref.org/works/10.1080/15622970801896390

21 January 2018

Identifiers

10.1080/15622970801896390

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33319816&oldid=2136094893"